The Canadian Jewellers Association (CJA) National Retail Report for December 2025 data, published in early January 2026, indicates muted overall retail sales growth in Canada, while jewellery and related discretionary categories continue to outperform. The monthly retail performance bulletin, prepared by the J.C. Williams Group and released by the trade association, offers insights valuable to global retail observers, market analysts and industry decision-makers. National retail snapshot: subdued growth ...

Core Insights - Honda reported earnings of $0.97 per share for Q1 fiscal 2026, exceeding the Zacks Consensus Estimate of $0.51, but down from $1.57 in the same quarter last year [1][10] - Quarterly revenues reached $37 billion, slightly below the Zacks Consensus Estimate of $37.8 billion, but higher than $34.7 billion from the previous year [1] Segmental Highlights - The Automobile segment's revenues increased by 1.1% year over year to ¥3.54 trillion ($24.4 billion), but it incurred an operating loss of ¥29.6 billion ($204 million), contrasting with an operating income of ¥222.8 billion in the same quarter last year [2] - Motorcycle segment revenues were approximately ¥951.6 billion ($6.58 billion), up 1.5% year over year, with an operating profit of ¥189 billion ($1.30 billion), reflecting a 6.8% increase year over year [3] - Financial Services segment revenues totaled ¥832.6 billion ($5.76 billion), down 11.4% year over year, with operating profit remaining flat at ¥85 billion ($588 million) [3] - Power Products and Other Businesses generated revenues of ¥92.8 billion ($641 million), a decrease of 2.2% year over year, but the operating loss narrowed to ¥219 million from ¥753 million in the same period last year [4] Financials & FY26 Outlook - As of June 30, 2025, Honda's consolidated cash and cash equivalents stood at ¥4.01 trillion ($27.7 billion), with long-term debt around ¥6.95 trillion ($48.1 billion) [5] - For fiscal 2026, Honda projects consolidated sales volumes of 14.25 million units for Motorcycles, 2.83 million units for Automobiles, and 3.67 million units for Power Products, indicating a 4.1% growth in Motorcycles but declines of 0.3% and 0.8% in Automobiles and Power Products, respectively [6] - Honda forecasts fiscal 2026 revenues of ¥21.1 trillion, a decline of 2.7% year over year, with an operating profit expected at ¥700 billion, down 42.3% year over year, and a pretax profit forecasted at ¥710 billion, suggesting a drop of 46.1% year over year, attributed to macroeconomic and tariff-related challenges [7]

Core Insights - Thermo Fisher Scientific Inc. (TMO) is focused on growth through strategic acquisitions and product launches, while facing challenges from macroeconomic volatility and foreign currency exchange [1][9][10] Financial Performance - TMO's stock has increased by 20.6% over the past year, outperforming the industry which declined by 11.3% and the S&P 500 which gained 10.2% [2] - The company has a market capitalization of $158.1 billion and an earnings yield of 5.3%, significantly higher than the industry's -2.8% [2] - TMO has consistently surpassed earnings estimates over the past four quarters, with an average surprise of 2.3% [2] Growth Strategies - A notable acquisition includes Solventum's Purification & Filtration business for $4.1 billion, expected to enhance TMO's biologics capabilities and deliver $125 million in adjusted operating income synergies over five years [3][7] - The acquisition of Olink has strengthened TMO's position in the high-growth proteomics market [3][7] - Recent product launches include the CorEvitas Adolescent Alopecia Areata Registry and the Invitrogen EVOS S1000 Spatial Imaging System, aimed at addressing specific market needs [4][7] Research and Development - TMO is increasing its R&D investments, with a projected 51.1% rise in R&D expenses for the second quarter of 2025 [5] Financial Health - As of March 29, 2025, TMO has a long-term debt of $31.37 billion, with cash and cash equivalents totaling $5.95 billion, indicating strong liquidity [8] - The times interest earned ratio stands at 6.3%, reflecting stable solvency [8] Macroeconomic Challenges - TMO is facing macroeconomic challenges, including geopolitical tensions and supply chain disruptions, which may impact profitability [9] - The company has experienced a 1% unfavorable effect on revenues in Q1 2025 due to currency translation from a stronger U.S. dollar [10] Earnings Estimates - The Zacks Consensus Estimate for TMO's earnings per share (EPS) has increased to $22.34, with 2025 revenue estimates at $43.71 billion, indicating a 1.9% rise from the previous year [11]

Core Insights - Energizer Holdings, Inc. reported second-quarter fiscal 2025 results with both net sales and earnings falling short of the Zacks Consensus Estimate, showing a year-over-year decline in both metrics [1][3][4] Financial Performance - Adjusted earnings were 67 cents per share, missing the estimate of 68 cents, and decreased by 6.9% from the previous year [4] - Net sales totaled $662.9 million, below the estimate of $669 million, and slightly decreased by 0.1% year-over-year, while organic net sales increased by 1.4% [4][5] - The battery segment saw a modest growth of 1.5% year-over-year, reaching $488 million, while the Auto Care segment experienced a decline of 4.1% to $174.9 million [6] Margin and Cost Analysis - Adjusted gross profit was $270.4 million, up 0.6% year-over-year, with an adjusted gross margin of 40.8%, an increase of 30 basis points [7] - Adjusted SG&A expenses rose by 9.3% year-over-year to $124.5 million, primarily due to investments in digital transformation and growth initiatives [8] - Adjusted EBITDA was $140.3 million, down 1.5% year-over-year, with an adjusted EBITDA margin of 21.2% [10] Financial Health - As of March 31, 2024, cash and cash equivalents stood at $139.3 million, with long-term debt of $3.15 billion and shareholders' equity of $133.9 million [11] - Operating cash flow for the fiscal second quarter was $64.2 million, and free cash flow was $8.6 million [11] Future Outlook - The company lowered its full-year guidance due to ongoing macroeconomic challenges, now expecting reported and organic net sales to range from flat to up 2% [3][13] - Adjusted EBITDA is projected to be between $610 million and $630 million, and adjusted earnings per share are expected to be in the range of $3.30 to $3.50 [14] - For the third quarter, reported and organic net sales are anticipated to be flat to down 2%, with adjusted EPS projected between 55 cents and 65 cents [15]

Core Insights - Reddit's first-quarter earnings exceeded Wall Street expectations, with revenue rising 61% year over year and net income of $26.2 million compared to a net loss of $575.1 million a year ago [1] - The company provided optimistic second-quarter sales guidance of $410 million to $430 million, surpassing analyst expectations of $396 million [1] - Reddit's daily active uniques (DAUq) increased by 31% year over year to 108.1 million, exceeding analyst expectations of 107.3 million [2] Financial Performance - First-quarter revenue was reported at $392 million, beating expectations of $370 million [7] - Earnings per share were 13 cents, significantly higher than the expected 2 cents [7] - The company’s net income improved from a significant loss in the previous year, indicating a strong recovery post-IPO [1] User Growth and Engagement - Global logged-in DAUq rose 23% year over year to 48.7 million, while logged-out DAUq increased by 38% to 59.4 million [4] - The increase in users is attributed to changes in Google search algorithms and site improvements aimed at converting logged-out users to logged-in users, which are more valuable for advertising [3][4] Market Context - Reddit's performance is set against a backdrop of macroeconomic challenges, with the CEO noting that such environments create both challenges and opportunities [1] - Other companies in the industry, such as Meta and Snap, are also facing varying degrees of macroeconomic headwinds, indicating a broader trend affecting digital advertising [5][6]

Core Insights - STERIS plc's Healthcare business is experiencing growth due to strong U.S. procedure volumes, favorable pricing, and market share gains, particularly in the Applied Sterilization Technologies (AST) segment [1][4][6] - The company has shown resilience in its stock performance, with a 10.4% increase over the past year, contrasting with a 10.4% decline in the industry [2] - Financial health indicators are positive, with a market capitalization of $22.01 billion and an earnings yield of 4.4%, significantly higher than the industry's -3.2% [2] Healthcare Segment Performance - The Healthcare segment reported a 7% year-over-year revenue growth in the third quarter of fiscal 2025, driven by a 9% increase in consumable revenues and a 13% rise in service revenues [4] - Order growth exceeded 10% in the fiscal third quarter, resulting in a healthcare backlog of $435 million [5] - Margins improved due to increased volume, favorable pricing, and productivity gains that offset labor inflation [5] AST Segment Insights - The AST segment achieved a 10% year-over-year growth in the fiscal third quarter, with service revenues also increasing by 10% [6] - The company is witnessing a rebound in bioprocessing demand and stable global demand from MedTech customers, with expectations for continued growth in bioprocessing revenues [6] Financial Health - As of the fiscal third quarter, STERIS reduced its long-term debt to $2.04 billion, a 5.6% decrease from the previous quarter [7] - The company had cash and cash equivalents of $155.2 million, exceeding its short-term debt of $125 million, resulting in a total debt-to-capital ratio of 25.2% [7] Macroeconomic Challenges - The global macroeconomic environment poses challenges, with rising healthcare costs impacting the company's financial operations [8][10] - Foreign currency exchange rate fluctuations affect nearly 30% of the company's revenues and costs, leading to a revised revenue growth rate of approximately 6% due to negative currency impacts [11]

Core Viewpoint - J.P. Morgan analyst Christian Carlino maintains a Neutral rating on Holley Inc. due to concerns over growth catalysts and macroeconomic challenges impacting the company [1] Group 1: Financial Performance and Projections - Holley's 2025 guidance indicates a potential achievement of a 20% EBITDA margin, but overall sentiment may be affected by a "softer" top-line outlook [1] - The analyst forecasts first-quarter sales of $144 million, reflecting a 2% organic decline, and total sales for the year at $590 million, down 2% year-over-year, with organic growth projected at 2.5% [4] - Direct-to-consumer sales increased by 8% in the fourth quarter, supported by improved marketing efforts, while sales through national retailers rose by 12% due to expanded SKU offerings [3] Group 2: Market Dynamics and Challenges - Softer revenue projections are likely to influence market sentiment, particularly in the current consumer environment [2] - Holley's market share performance in the fourth quarter was affected by distribution partners reducing safety stock, attributed to the company's enhanced supply chain capabilities [2] - Sales guidance for the year is skewed towards the second half, with initial pressures from consumer confidence and weather conditions impacting the first quarter [4] Group 3: Stock Performance - HLLY shares are currently trading higher by 0.61% at $2.485 [4]